UCB Sells S Asia Established Drugs Business To Dr. Reddy’s
This article was originally published in PharmAsia News
Executive Summary
Belgium’s UCB will sell its established products business in India to Dr. Reddy’s Labs – a move it said will help it grow its innovative neurology drugs portfolio. The Indian company expects to gain an edge in areas like respiratory, dermatology and pediatrics.